Advanced Platelet-rich Fibrin Combined With Open Debridement in Management of Suprabony Periodontal Defects
Clinical and Radiographic Evaluation of Advanced Platelet Rich Fibrin and Open Debridement in Management of Periodontal Suprabony Defects
1 other identifier
interventional
30
1 country
1
Brief Summary
in this clinical trial, patients with periodontal defects will be treated with advanced platelet-rich fibrin in conjunction with open debridement
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Nov 2021
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 27, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 26, 2022
CompletedFirst Submitted
Initial submission to the registry
February 7, 2023
CompletedFirst Posted
Study publicly available on registry
February 15, 2023
CompletedMarch 27, 2023
February 1, 2023
2 months
February 7, 2023
March 23, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
clinical evaluation
Rate of probing pocket depth reduction
6 months
Secondary Outcomes (1)
radiographic evaluation
6 months
Study Arms (2)
group 1
ACTIVE COMPARATORgroup 2
SHAM COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- patients with periodontal suprabony defects.
You may not qualify if:
- pregnant females.
- smokers.
- systemic disease that contraindicate surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Al-Azhar University, Faculty of Dentistry
Cairo, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
February 7, 2023
First Posted
February 15, 2023
Study Start
November 21, 2021
Primary Completion
January 27, 2022
Study Completion
July 26, 2022
Last Updated
March 27, 2023
Record last verified: 2023-02